机构：[1]Fudan Univ, Huashan Hosp, Inst Neurol, Shanghai 200433, Peoples R China;[2]Capital Med Univ, Beijing Tiantan Hosp, Beijing, Peoples R China;首都医科大学附属天坛医院[3]Beijing Union Med Coll Hosp, Dept Neurol, Beijing, Peoples R China;[4]Minist Publ Hlth, Beijing Hosp, Beijing, Peoples R China;[5]Kantonsspital Basel, Basel, Switzerland;[6]Bayer Healthcare China Co Ltd, Med & Sci Affairs Dept, Shanghai Branch, Shanghai, Peoples R China;[7]Bayer Schering Pharma AG, Bayer Healthcare, Global Clin Dev Clin Stat, Berlin, Germany;[8]Bayer Schering Pharma AG, Bayer Healthcare, Global Clin Dev Specialized Therapeut TA Neurol O, Berlin, Germany
Lv C.,Zhang X. H.,Cui L. Y.,et al.Evaluation of efficacy, safety and tolerability of interferon beta 1b in patients of Chinese origin with multiple sclerosis[J].JOURNAL OF THE NEUROLOGICAL SCIENCES.2009,285:S115-S115.doi:10.1016/S0022-510X(09)70461-7.
APA：
Lv, C.,Zhang, X. H.,Cui, L. Y.,Xu, X. H.,Radue, E. W....&Sandbrink, R..(2009).Evaluation of efficacy, safety and tolerability of interferon beta 1b in patients of Chinese origin with multiple sclerosis.JOURNAL OF THE NEUROLOGICAL SCIENCES,285,
MLA：
Lv, C.,et al."Evaluation of efficacy, safety and tolerability of interferon beta 1b in patients of Chinese origin with multiple sclerosis".JOURNAL OF THE NEUROLOGICAL SCIENCES 285.(2009):S115-S115
